35 results about "Chronic insufficiency" patented technology

Endovascular prostheses are disclosed that are configured to repair a native venous valve having improper or non-existent valve leaflet coaptation caused by vessel weakness and/or distention. The prostheses are configured to be implanted in the venous system immediately downstream of the malfunctioning valve and act as repair devices to restore proper function to the venous valve by reconfiguring and supporting the valve leaflets and thereby improving their coaptation.

The invention discloses a medicine for treating chronic renal insufficiency and chronic renal failure diseases. The medicine comprises the following raw materials in parts by weight: 70-90 parts of hairy antler, 17-23 parts of prepared common monkshood daughter root, 70-90 parts of cassia twig and 170-230 parts of all-grass of desertliving cistanche; preferably, the medicine also comprises the following raw materials in parts by weight: 170-230 parts of common macrocarpium fruit, 85-115 parts of prepared rhizome of rehmannia, 170-230 parts of largehead atractylodes rhizome, 170-230 parts of Chinese angelica and 45-55 parts of astragalus membranaceus; preferably, the medicine also comprises the following raw materials in parts by weight: 170-230 parts of Indian buead, 170-230 parts of plantain seed and 17-23 parts of root-bark of tree peony; and preferably, the medicine also comprises the following raw materials in parts by weight: 85-115 parts of twotooth achyranthes root and 45-55 parts of rheum rhabarbarum. The medicine disclosed by the invention can be used for tonifying the kidney-qi, strengthening the kidney-yang and recovering the renal functions, and can be used for treating chronic renal insufficiency, chronic renal failure, limb weakness, waist-knee-limb coldness, difficult urination, frequent urination or nighttime micturition, bleak or dark complexion, sluggish in facial expression, double-limb pitting edema, face and eye edema, urea nitrogen increase, creatinine increase, hypertensive nephropathy and diabetic nephropathy caused by insufficiency of kidney-yang, and treating the chronic renal insufficiency and chronic renal failure diseases caused by medicine injury or other reasons.

The invention is related to the use of a Chinese medicine composition serving for preparing drug for curing chronic cardiac insufficiency. The composition is formed of the following raw materials by weight: 22.2% to 66.8% of astragalus, 11.6% to 33.4% of salvia, 2.5% to 13.5% of panax notoginseng, 14.5% to 44.3% of lignum dalbergiae odoriferae.

An application of the pueraria flavone in preparing the medicines for treating chronic cerebral ischemia is disclosed. Its preparing process includes such steps as providing pueraris roots, extracting in water or alcohol, concentrating, depositing in alcohol, purifying by chromatography, eluting and spray drying.

An application of the medicinal composition composed of 18 Chinese-medicinal materials including Chinese angelica root, astragalus root, red peony root, Chuan-xiong rhizome, etc in preparing the medicines for treating chronic cerebral ischemia is disclosed.

The present invention discloses a Chinese medicine for curing chronic nephritis and chronic renal insufficiency with obvious therapeutic effect and small size effect. Said invention is made up by using 7 Chinese medicinal materials of centella, cornus fruit, ligusticum root, astragalus root, salvia root and others.

An application of the gingko leaf's extract (pueraria flavone) in preparing the medicine for treating chronic cerebral ischemia is disclosed. A process for preparing said pueraria flavone is also disclosed.

An application of the medicinal composition composed of Chuan-xiong rhizome, pueraria root and puncturevine caltrop in preparing the medicine for treating chronic cerebral ischemia is disclosed.

An application of the medicinal composition composed of auxiliary choerosponidas fruit, red sage root, cloves, borneol, etc in preparing the medicines for treating chronic cerebral ischemia is disclosed.

A Chinese medicine for treating chronic renal insufficiency is prepared from 14 Chinese-medicinal materials including red sage root, astragalus root, red peony root, rhubarb, etc through respectively pre-treating and proportional dispensing.

An application of the medicinal composition composed of corydalis tube, northern siphonostegia, fortume's drynaria rhizome and ginseng in preparing the medicines for treating chronic cerebral ischemia is disclosed.

The invention provides a traditional Chinese medicine clysis fluid for treating chronic renal insufficiency and yang deficiency-induced cold of diabetic nephropathy. The traditional Chinese medicine clysis fluid is prepared from the following Chinese herbs: 100g of prepared rhubarb, 100g of dragon's bone, 100g of oyster, 75g of dandelion, 50g of processed radix aconiti lateralis, 50g of cinnamon, 50g of cassia twig, 50g of szechuan lovage rhizome, 50g of safflower, 50g of poria cocos, 50g of agaric, 50g of rose, 50g of hawthorn, 50g of notoginseng powder, 50g of hairyvein agrimonia herband bud, 50g of corydalis tuber, 50g of peach kernel, 50g of root of bidentate achyranthes, suberect spatholobus stem, 50g of dragon's blood, 25g of frankincense, 25g of myrrh, 50g of root of doubleteeth pubescent angelica, 50g of incised notopterygium, 50g of Chinese rose flower, 50g of India mustard seed, 50g of amber powder, 50g of yam rhizome, 50g of thinleaf milkwort root-bark, 50g of silktree albizzia bark, 50g of gecko, 100g of Chinese yam, 75g of manyprickle acanthopanax root, 50g of medicinal Indian mulberry, 50g of walnut kernel, 50g of songaria cynomorium herb, 50g of tuber fleeceflower root, 50g of Chinese angelica, 100g of tortoise shell, 100g of turtle shell, 50g of malaytea scurfpea fruit and 100g of black chicken bone. The traditional Chinese medicine clysis fluid has the effects of activating blood to dissipate stasis, relieving swelling and pain, eliminating cold to stop pain, clearing damp and promoting diuresis and the like, is capable of effectively covering the shortage that the conventional treatment by use of single western medicine is high in side effect and fails in correcting the yang deficiency-induced cold symptom, and is short in course of treatment and low in side effect.

An application of the medical composition composed of red sage root, notoginseng and dalbergia wool oil in preparing the medicines for treating chronic cerebral ischemia is disclosed.

The invention discloses a pharmaceutical preparation for treating progressive muscular atrophy, cerebral hemorrhage sequelae and cardiac insufficiency, and a preparation method thereof. The pharmaceutical preparation for treating progressive muscular atrophy, cerebral hemorrhage sequelae and cardiac insufficiency is prepared from the following components in parts by weight: 100 parts of adenosine disodium triphosphate, 200-400 parts of sodium alginate, 100-200 parts of hydroxypropyl methylcellulose, 400-800 parts of glucan, 50-200 parts of sodium carboxymethyl starch, 50-100 parts of sodium dodecyl sulfate, 15-30 parts of a micropowder silica gel and 15-30 parts of magnesium stearate. According to the preparation method disclosed by the invention, the adenosine disodium triphosphate is prepared into an inclusion compound by a sodium alginate swelling technique, and then the main drug inclusion compound is further prepared into dispersible tablets. The adenosine disodium triphosphate in the product disclosed by the invention has increased dissolubility, higher dissolution rate, shortened disintegration time limited and improved bioavailability, thereby improving the curative effect, and the preparation method has simple process, low production cost, low energy consumption and easy implementation of industrialized production.

A medicine for acute or chronic cardiac disfunction is disclosed. Its advantages are high natural level and safety and low toxic by-effect.

An application of the medicinal composition composed of ginseng and white peony root in preparing the medicines for treating chronic cerebral ischemia is disclosed.